Issue Date | Title | Author(s) |
2023 | Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China | Hua, Rui; Kong, Fei; Li, Guangming; Wen, Xiaofeng; Zhang, Yuexin; Yang, Xingxiang; Meng, Chenxin; Xie, Wen; Jiang, Yongfang; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Mao, Qing; Wang, Jiefei; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Xiong, Qingfang; Ma, Hong; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Zhu, Liying; Mao, Xiaorong; Lian, Jianqi; Deng, Guojiong; Xin, Yongning; Wang, Yifei; Ye, Yinong; Xu, Bin; Gao, Hainv; Tan, Youwen; Li, Dongliang; Yang, Dongliang; Su, Minghua; Zhang, Xiaomeng; Min, Jie; Shi, Xinsheng; Wei, Lai; Niu, Junqi |
2019 | All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china | Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
2015 | A correlativity study of plasma APL1 beta 28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients | Meng, Ying; Li, Huiying; Hua, Rui; Wang, Huali; Lu, Jian; Yu, Xin; Zhang, Chen |
2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
2019 | Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China | Xu, Xiaoyuan; Feng, Bo; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; Anl, Ping; Gong, Guozhong; Liu, Huimin; Nine, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, Fusheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi J.; Wei, Lai |
2019 | THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL | Wei, Lai; Xu, Xiaoyuan; Zheng, Sujun; Guan, Yujuan; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qing; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang, Sr.; Chen, Liang; Ye, Yinong, Sr.; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
2016 | In vivo metabolic labeling of sialoglycans in the mouse brain by using a liposome-assisted bioorthogonal reporter strategy | Xie, Ran; Dong, Lu; Du, Yifei; Zhu, Yuntao; Hua, Rui; Zhang, Chen; Chen, Xing |
2018 | A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma | Luo, Ping; Yin, Peiyuan; Hua, Rui; Tan, Yexiong; Li, Zaifang; Qiu, Gaokun; Yin, Zhenyu; Xie, Xingwang; Wang, Xiaomei; Chen, Wenbin; Zhou, Lina; Wang, Xiaolin; Li, Yanli; Chen, Hongsong; Gao, Ling; Lu, Xin; Wu, Tangchun; Wang, Hongyang; Niu, Junqi; Xu, Guowang |
2015 | An optimized method for high-titer lentivirus preparations without ultracentrifugation | Jiang, Wei; Hua, Rui; Wei, Mengping; Li, Chenhong; Qiu, Zilong; Yang, Xiaofei; Zhang, Chen |
Jul-2021 | SH229 plus daclatasvir for treatment of chronic hepatitis C virus infection in China: a single-arm, open-label, phase 3 study | Hua, Rui; Kong, Fei; Wen, Xiaofeng; Yang, Xingxiang; Meng, Chenxin; Jiang, Yongfang; Xie, Wen; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Wang, Jiefei; Mao, Qing; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Ma, Hong; Xiong, Qingfang; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Mao, Xiaorong; Lian, Jianqi; Zhu, Liying; Xin, Yongning; Deng, Guojiong; Wang, Yifei; Xu, Bin; Gao, Hainv; Tan, Youwen; Ye, Yinong; Li, Dongliang; Yang, Dongliang; Su, Minghua; Li, Cheng; Shen, Xian; Wu, Qiong; Zhang, Xian; Wang, Zhiqiang; Zhao, Liwen; Zhang, Yuexin; Li, Guangming; Niu, Junqi |
2015 | The trans-SNARE-regulating function of Munc18-1 is essential to synaptic exocytosis | Shen, Chong; Rathore, Shailendra S.; Yu, Haijia; Gulbranson, Daniel R.; Hua, Rui; Zhang, Chen; Schoppa, Nathan E.; Shen, Jingshi |